Corcept's Q2 2025 saw 60% therapy demand growth despite bottlenecks. Despite near-term operational risks, we maintain ...

Baron Capital’s Q2 report highlights biotech, surgical tech, and GLP-1 winners. Discover which health care stocks surged and ...

A New York Fed report shows credit card delinquency rates for Americans under 40 remain unusually elevated, with Gen Z facing increasing financial pressures.

Q2 2025 Management View Khozema Z. Shipchandler, CEO, reported, "Twilio had a strong Q2, reaching over $1.2 billion in ...

What does a multi-billion-dollar trade surplus mean if rural families still have to choose between paying the electricity ...

A late-stage study tested three doses of Eli Lilly’s oral GLP-1 drug, Orforglipron, in more than 3,100 adults, with the ...

Tesla's latest financial results suggest the Elon Musk-led company will continue to face challenges in the latter half of 2025.